A particular signaling protein in the brain could be a therapeutic target for neurological disorders arising from the deletion of the autism-linked gene MEF2C, University of Illinois Urbana-Champaign researchers found in a new mouse study published in the journal Proceedings of the National Academy of Sciences.
Neural Signaling Protein Identified as Potential Autism Treatment Target
Researchers at the University of Illinois Urbana-Champaign discovered a signaling protein in the brain that could be targeted for therapies related to neurological disorders linked to the autism-associated gene MEF2C. This study, published in a prominent journal, highlights potential advancements in understanding autism-related conditions. The implications for Iran lie in the potential for improved mental health treatments, which could benefit the population.
🏷️ Entities Mentioned
Translated from the original and edited for English readers. View original source →
Translation confidence: 100%